These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 170838

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma and other neoplastic conditions.
    Kottaridis SD, Dafnou M, Besbeas S, Garas J.
    J Natl Cancer Inst; 1977 Jul; 59(1):89-91. PubMed ID: 195074
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Epstein-Barr virus-associated antibodies and serum biochemistry in nasopharyngeal carcinoma.
    Lynn TC, Hsieh RP, Chuang CY, Huang SC, Hsieh T, Tu SM.
    Laryngoscope; 1984 Nov; 94(11 Pt 1):1485-8. PubMed ID: 6092804
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Letter: Epstein-Barr virus and carcinoma.
    Rossouw E, Bey E, Joosting AC, Gear JH.
    S Afr Med J; 1976 Mar 27; 50(14):529. PubMed ID: 179156
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups.
    Henle W, Henle G, Ho HC, Burtin P, Cachin Y, Clifford P, de Schryver A, de-Thé G, Diehl V, Klein G.
    J Natl Cancer Inst; 1970 Jan 27; 44(1):225-31. PubMed ID: 11515035
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma.
    Cheng YC, Chen JY, Glaser R, Henle W.
    Proc Natl Acad Sci U S A; 1980 Oct 27; 77(10):6162-5. PubMed ID: 6255477
    [Abstract] [Full Text] [Related]

  • 36. Epstein-Barr virus-related antibody. Changes in titers after therapy for nasopharyngeal carcinoma.
    Neel HB, Taylor WF.
    Arch Otolaryngol Head Neck Surg; 1990 Nov 27; 116(11):1287-90. PubMed ID: 2173618
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Serum anti-EBV IgA is inversely related to tumor infiltration by surface IgA positive lymphocytes in nasopharyngeal carcinoma.
    Gunvén P, Klein G, Henle W, Henle G, Forsby N.
    Biomed Pharmacother; 1983 Nov 27; 37(1):41-4. PubMed ID: 6311307
    [Abstract] [Full Text] [Related]

  • 40. An immunoperoxidase assay for the detection of specific IgA antibody in Epstein-Barr virus infections.
    Cevenini R, Donati M, Rumpianesi F, Moroni A, Paolucci P.
    J Clin Pathol; 1984 Apr 27; 37(4):440-3. PubMed ID: 6323549
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.